Indrayani Biotech shareholding pattern

INDRANIB

11.1

0.52 (4.91%)
Last updated on 1 Jun, 2026 | 15:09 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Indrayani Biotech Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

33.26%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

66.74%

Others

0%

Total Promoters
MAR '25
33.28%
JUN '25
33.28%
SEP '25
33.26%
DEC '25
33.26%

Summary

Indrayani Biotech share holding pattern reports the following shareholding: Indrayani Biotech Total Promoters is at 33.26%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 0.00%, Domestic Institutional Investors at 0.00%, and Retail at 66.74%. This breakdown provides a quick snapshot of ownership distribution for Indrayani Biotech share holding pattern in 2026-27.

Indrayani Biotech FAQs

As of 06-2026, the promoter shareholding in Indrayani Biotech stands at 33.26% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Indrayani Biotech is 0% and 0% respectively.

The retail shareholding of the Indrayani Biotech is 66.74%.

Changes in shareholding patterns of Indrayani Biotech can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Indrayani Biotech are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost